ADPT logo

ADPT Adaptive Biotechnologies Corporation

NASDAQ Global Select · Biotechnology · Healthcare

$24.77
+0.03 (+0.12%)

Adaptive Biotechnologies Corporation, founded in 2009 and headquartered in Seattle, Washington (operating as Adaptive TCR Corporation until its name change in December 2011), is a commercial-stage entity focused on pioneering an immune medicine platform. This advanced platform is engineered for the precise diagnosis and effective treatment of a broad spectrum of illnesses. The company offers sever…

Market Cap: $3.96Bwww.adaptivebiotech.com

Price

No data yet.

Social Signal Score

50
5d
51
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Revenue

$71.55M+81.30%
$37.65M$56.42M$75.20M$93.97M
Sep 2021Jun 2026